Published in Biotech Law Weekly, October 29th, 2004
"While we have been pleased with the clinical performance and technical advances offered by the Symmetry Anastomotic device, and continue to believe in the value this technology provides, business conditions in this area have proven to be increasingly challenging," said George J. Fazio, president, Cardiac Surgery Division.
"We will continue to support our customers and their patients," said Fazio. "As part of these efforts,...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Biotech Law Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.